HAL (France)open access
Adjuvant Atezolizumab for Early Triple-Negative Breast Cancer: The ALEXANDRA/IMpassion030 Randomized Clinical Trial
Breast Cancer, Chemotherapeutic drug, 1, 0
This document is indexed with metadata only — full text is not available in the archive for this record.
Open the official source ↗
Record · ID 250324
Retrieved via
Conceptio — every document is proof-bundled with source, license, and retrieval metadata.